Results 311 to 320 of about 127,348 (379)

Immunophenotypic abnormality quantification refines multiparameter flow cytometry‐based measurable residual disease testing in adults allografted for acute myeloid leukemia in morphologic remission

open access: yesHemaSphere, Volume 10, Issue 2, February 2026.
Abstract Flow cytometry‐based measurable residual disease (MRD) testing is routinely used in acute myeloid leukemia (AML), but methodologies need refinement to optimize assay characteristics. Here, we examined 1215 adults with AML or myelodysplastic syndrome/AML allografted in morphologic remission to study how the type(s) of leukemic blasts and degree/
Calvin M. Le   +8 more
wiley   +1 more source

A Case of Isolated Autoimmune Ureteritis in A 25-Year-Old Male. [PDF]

open access: yesEur J Case Rep Intern Med
Hogea ICG   +4 more
europepmc   +1 more source

Model Informed Precision Dosing of Tacrolimus in Children Following Heart Transplant

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 2, February 2026.
Abstract Tacrolimus is a first‐line immunosuppressant used after solid organ transplantation that suffers from extensive intra‐ and inter‐patient variability and a narrow therapeutic window. Its critical role in a fragile population, coupled with the difficulties identifying and maintaining an appropriate dose within a given patient, make it an ideal ...
Jadon S. Wagstaff   +3 more
wiley   +1 more source

Neuro‐Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 2, February 2026.
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo   +11 more
wiley   +1 more source

Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus. [PDF]

open access: yesSci Rep
Bortoluzzi A   +41 more
europepmc   +1 more source

Reproductive health in the liver transplant recipient. [PDF]

open access: yesLiver Transpl
Dukewich M   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy